GHRL and obesity due to melanocortin 4 receptor deficiency: These qualities have created the idea that compounds having the ability to suppress the action of ghrelin may be valuable for the prevention or treatment of overweight, obesity, insulin resistance, and abnormal lipid and glucose metabolism (9, 10).